Thus, there is an urgent need for new drugs for the treatment of negative symptoms and cognitive deficits of schizophrenia, which might be achieved by understanding the interaction between DAO and DAOA, and their subsequent effect on NMDA receptors. The gene discussed is DAO; the disease is schizophrenia.